What is respiratory syncytial virus (RSV)?

RSV is a common seasonal virus. RSV begins with cold-like symptoms but can spread to the lungs. RSV affects people of all ages, but in adults RSV infections are generally minor. However, older adults can sometimes have serious complications, including inflammation of the lungs or pneumonia.

These clinical trials are important as there is currently no vaccine for RSV. Participants will help us in our fight to prevent RSV in older adults in the future.

What are the RSV studies?

The RSV studies are looking at investigational vaccines against respiratory syncytial virus (RSV). Doctors in local research studies are looking at potential new investigational vaccines for RSV. They are evaluating how safe investigation vaccines are and whether they can improve a patient’s quality of life. These investigational vaccines can only be given to patients as part of clinical research studies. We are looking for older adults to take part in the studies.

People who qualify may receive compensation for time and travel, investigational study interventions at no cost, and care from study doctors at no cost. Some people participate in research studies to contribute to medical science and help doctors find other ways to help patients.

To find out if you qualify for one of these studies, complete the survey now. There is no obligation and health insurance is not required.